Top compounds associated with response to MTX1


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 1e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 2e-06
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.17 6e-06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 8e-06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.13 5e-05
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA tivozanib CTRPv2 pan-cancer AAC -0.13 0.0004
Download CSV